Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

831 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia.
Talpaz M, Kantarjian H, Kurzrock R, Gutterman JU. Talpaz M, et al. Among authors: kurzrock r. Cancer. 1992 Jan 15;69(2):410-2. doi: 10.1002/1097-0142(19920115)69:2<410::aid-cncr2820690222>3.0.co;2-v. Cancer. 1992. PMID: 1370212
Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
Estrov Z, Estey EH, Andreeff M, Talpaz M, Kurzrock R, Reading CL, Deisseroth AB, Gutterman JU. Estrov Z, et al. Among authors: kurzrock r. Exp Hematol. 1992 Jun;20(5):558-64. Exp Hematol. 1992. PMID: 1587302
Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity.
Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D, Gutterman JU, Talpaz M. Estrov Z, et al. Among authors: kurzrock r. Blood. 1991 Sep 15;78(6):1476-84. Blood. 1991. PMID: 1715791
Interferon-stimulated genes in interferon-sensitive and -resistant chronic myelogenous leukemia patients.
Talpaz M, Chernajovsky Y, Troutman-Worden K, Wetzler M, Kantarjian H, Gutterman JU, Kurzrock R. Talpaz M, et al. Among authors: kurzrock r. Cancer Res. 1992 Mar 1;52(5):1087-90. Cancer Res. 1992. PMID: 1737366
Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies.
Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. Baiocchi G, et al. Among authors: kurzrock r. Cancer. 1991 Feb 15;67(4):990-6. doi: 10.1002/1097-0142(19910215)67:4<990::aid-cncr2820670422>3.0.co;2-8. Cancer. 1991. PMID: 1825026
Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia.
Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M. Schilling PJ, et al. Among authors: kurzrock r. Cancer. 1991 Oct 1;68(7):1536-7. doi: 10.1002/1097-0142(19911001)68:7<1536::aid-cncr2820680713>3.0.co;2-b. Cancer. 1991. PMID: 1893353
A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia.
Talpaz M, Kurzrock R, Kantarjian H, Rothberg J, Saks S, Evans L, Gutterman JU. Talpaz M, et al. Among authors: kurzrock r. Cancer. 1991 Nov 15;68(10):2125-30. doi: 10.1002/1097-0142(19911115)68:10<2125::aid-cncr2820681006>3.0.co;2-q. Cancer. 1991. PMID: 1913450 Clinical Trial.
Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia.
Estrov Z, Talpaz M, Chou TC, Kurzrock R, Blake M, Gutterman JU. Estrov Z, et al. Among authors: kurzrock r. Leukemia. 1991 Feb;5(2):101-7. Leukemia. 1991. PMID: 2020193
Constitutive and induced expression of growth factors in normal and chronic phase chronic myelogenous leukemia Ph1 bone marrow stroma.
Wetzler M, Kurzrock R, Taylor K, Spitzer G, Kantarjian H, Baiocchi G, Ku S, Gutterman JU, Talpaz M. Wetzler M, et al. Among authors: kurzrock r. Cancer Res. 1990 Sep 15;50(18):5801-5. Cancer Res. 1990. PMID: 2203522
831 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback